5201.T
Latest Trade
3,900.00JPYChange
-205.00(-4.99%)Volume
2,060,600Today's Range
-
4,020.0052 Week Range
-
4,125.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 4,105.00 |
|---|---|
Open | 4,005.00 |
Volume | 2,060,600 |
3M AVG Volume | 21.42 |
Today's High | 4,020.00 |
Today's Low | 3,900.00 |
52 Week High | 4,125.00 |
52 Week Low | 2,255.00 |
Shares Out (MIL) | 221.63 |
Market Cap (MIL) | 887,021.40 |
Forward P/E | 14.64 |
Dividend (Yield %) | 3.08 |
MolMed Bidder AGC To Complete Squeeze Out
MolMed Reports Final Results Of Tender Offer By AGC
MolMed Reports Provisional Results Of AGC Bid
AGC Inc., formerly Asahi Glass Company, Limited, is a glass manufacturer. The Glass segment manufactures and sells float plate glass, figured glass, low-E glass, processed glass for construction use, hardened glass and laminated glass for automobiles, and solar glass, among others. The Electronics segment is engaged in the manufacture and sale of glass substrates for display devices, special glass and peripheral components for display, optoelectronics parts, and glass frit paste, among others. The Chemical segment offers chloride vinyl monomers, sodium hydroxide, urethane raw materials, gas, solvent, fluorine resin, water and oil repellent, pharmaceutical and agrochemical intermediates and bulk and others. In addition, the Company is also involved in the manufacture and sale of ceramic products, and the provision of logistics and financial services.
Industry
Constr. - Supplies & Fixtures
Contact Info
1F, Shin-Marunouchi Bldg.
1-5-1, Marunouchi
CHIYODA-KU, TKY
100-8405
Japan
+81.3.32185741
https://www.agc.com/Executive Leadership
Takuya Shimamura
Executive President, Chief Executive Officer, Representative Director
Shinji Miyaji
Chief Financial Officer, Executive Vice President, Chief Compliance Officer, Chief Director of Business Planning, Representative Director
Toshiro Kasuya
Executive Officer, Director of Accounting & Finance
Yoshinori Hirai
Chief Technology Officer, Senior Managing Executive Officer, Representative Director
Masao Nemoto
Senior Managing Executive Officer, President of Chemicals Company
Price To Earnings (TTM) | 26.50 |
|---|---|
Price To Sales (TTM) | 0.63 |
Price To Book (MRQ) | 0.78 |
Price To Cash Flow (TTM) | 4.80 |
Total Debt To Equity (MRQ) | 70.66 |
LT Debt To Equity (MRQ) | 53.26 |
Return on Investment (TTM) | 2.31 |
Return on Equity (TTM) | 1.69 |
Italy said it would use its right to intervene to protect strategic assets on the planned acquisition of biotechnology group Molmed <MLMD.MI> by AGC <5201.T>, leaving the Japanese buyer to review whether to go ahead with its offer.
* BOARD UNANIMOUSLY APPROVED ISSUER'S STATEMENT IN RELATION TO OFFER ON ALL ORDINARY SHARES OF CO LAUNCHED BY AGC INC
Japan's AGC <5201.T> has launched a takeover bid on the whole of Italian biotech company Molmed <MLMD.MI> in a deal worth up to 240 million euros ($267 million), AGC said on Tuesday.
Japan's AGC has launched a takeover bid on all the shares of Italian biotech company Molmed in a deal worth up to 240 million euros ($267 million), AGC said in a statement on Tuesday.
* AGC LAUNCHES TAKEOVER BID AT EUR 0.518 PER SHARE Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.